Allan Rubenstein's Contact Details
- ar****@nexgenixpharm.com
- Company
- NexGenix Pharmaceuticals Holdings Inc
- Company Address
- New York NY
- Company Phone
- (917) 210-3377
About Allan Rubenstein
Allan E. Rubenstein, MD is Clinical Professor of Neurology and Pediatrics at NYU Langone Medical Center, New York. Dr. Rubenstein has spent most of his career in research on neurofibromatosis (NF) and related genetic disorders. Dr. Rubenstein founded the National NF Foundation (now Children's Tumor Foundation) in 1978, and from 1978 until 2003 he served as its Director of Medical Affairs. Currently he serves as Medical Director Emeritus. Dr. Rubenstein has authored several books on NF and has been a consultant to the NIH, FDA Orphan Drugs Program and the U.S. Department of Defense NF Research Program, where, from 2001 to 2002, he was Chairman of its Integration Panel. Since 1992 Dr. Rubenstein has served as Chairman and subsequently as Vice-Chairman and lead director of the Board of Directors of The Cooper Companies (COO, NYSE), a medical device company. He was also a member from 2000-2003 of the Board of Directors of Bioimaging Technologies (BITI, NASDAQ), a clinical research organization.
Allan Rubenstein's Current Workplace
- Headquarters
- 30 E 85th St Ste 3B, New York NY
- Phone Number
- (917) 210-3377
- Website
- nexgenixpharm.com
- Revenue
- 5200
- Employees
- 9
- Founded it
- 2003
- Industry
- Materials/Manufacturing
- NAICS Code
- 32541
Other People Named Allan Rubenstein
Match relevance is determined by profile alignment with job title and location, profession and industry, or users sharing the same last name.
Washington, District of Columbia, United States
Senior Software Engineer - Front-End Development at WillowTree
- Software
New York City Metropolitan Area
Member, Board of Directors at Visioneering Technologies Inc
- Medical Devices
FAQ
Email: ar****@nexgenixpharm.com